Inventiva Sa (IVA)

Currency in USD
6.530
+0.230(+3.65%)
Closed·
6.620+0.090(+1.38%)
·
IVA Scorecard
Full Analysis
RSI suggests the stock is in overbought territory
Unusual trading volume
Trading near 52-week High
IVA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
6.2606.547
52 wk Range
1.6006.547
Key Statistics
Prev. Close
6.3
Open
6.34
Day's Range
6.26-6.547
52 wk Range
1.6-6.547
Volume
113.13K
Average Volume (3m)
49.26K
1-Year Change
257.81%
Book Value / Share
-0.08
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
IVA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
14.030
Upside
+114.85%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts do not anticipate the company will be profitable this year

Inventiva Sa News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Inventiva Sa Company Profile

Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally. The company develops Lanifibranor, a novel pan-peroxisome proliferator-activated receptor agonist that is in the NATiV3 Phase 3 clinical trial to treat adult patients with MASH; and Odiparcil for the treatment of patients with mucopolysaccharidoses. It also develops TGF-ß, a pre-clinical program for the treatment of idiopathic pulmonary fibrosis. The company was incorporated in 2011 and is headquartered in Daix, France.

Compare IVA to Peers and Sector

Metrics to compare
IVA
Peers
Sector
Relationship
P/E Ratio
−2.4x−2.5x−0.7x
PEG Ratio
0.030.140.00
Price/Book
−83.4x1.4x2.6x
Price / LTM Sales
43.8x8.8x3.4x
Upside (Analyst Target)
137.4%170.2%35.5%
Fair Value Upside
Unlock3.6%3.3%Unlock

Analyst Ratings

8 Buy
1 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 14.030
(+114.85% Upside)

Earnings

Latest Release
Sep 29, 2025
EPS / Forecast
-1.76 / -0.6048
Revenue / Forecast
5.61M / --
EPS Revisions
Last 90 days

IVA Income Statement

People Also Watch

32.06
VSAT
+3.82%
127.98
NBIS
+1.68%
67.760
ASTS
+2.42%
6.79
RZLV
+8.13%
145.78
CRCL
-2.63%

FAQ

What Stock Exchange Does Inventiva Trade On?

Inventiva is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Inventiva?

The stock symbol for Inventiva is "IVA."

What Is the Inventiva Market Cap?

As of today, Inventiva market cap is 872.58M.

What Is Inventiva's Earnings Per Share (TTM)?

The Inventiva EPS (TTM) is -3.53.

When Is the Next Inventiva Earnings Date?

Inventiva will release its next earnings report on 20 Nov 2025.

From a Technical Analysis Perspective, Is IVA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Inventiva Stock Split?

Inventiva has split 0 times.

How Many Employees Does Inventiva Have?

Inventiva has 84 employees.

What is the current trading status of Inventiva (IVA)?

As of 04 Oct 2025, Inventiva (IVA) is trading at a price of 6.530, with a previous close of 6.30. The stock has fluctuated within a day range of 6.260 to 6.547, while its 52-week range spans from 1.600 to 6.547.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.